PMGC HOLDINGS INC. Increase (Decrease) in Prepaid Expense
PMGC HOLDINGS INC. (ELAB) reported Increase (Decrease) in Prepaid Expense of -$283.72 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2024-11-14
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense for the quarter ending 2024-09-30 was -$146.43K.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense for the quarter ending 2024-06-30 was -$274.25K.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense for the quarter ending 2024-03-31 was $136.95K, a 38.42% decline year-over-year.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense for the quarter ending 2023-12-31 was $768.71K.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense for fiscal 2023 was $907.34K, a 789.07% increase from fiscal 2022.
- PMGC HOLDINGS INC. increase (decrease) in prepaid expense for fiscal 2022 was $102.06K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | -$146.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$420.67K derived: sum of 2 quarters · filed 2024-11-14 | -$283.72K 10-Q · filed 2024-11-14 | $484.99K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-06-30 | -$274.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$137.29K 10-Q · filed 2024-08-14 | $631.41K derived: sum of 3 quarters · filed 2024-08-14 | $586.53K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-03-31 | $136.95K 10-Q · filed 2024-05-15 | $905.66K derived: sum of 2 quarters · filed 2024-05-15 | $860.78K derived: sum of 3 quarters · filed 2024-11-14 | $821.89K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-12-31 | $768.71K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $723.83K derived: sum of 2 quarters · filed 2024-11-14 | $684.94K derived: sum of 3 quarters · filed 2024-11-14 | $907.34K 10-K · filed 2024-03-29 | |
| 2023-09-30 | -$44.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$83.77K derived: sum of 2 quarters · filed 2024-11-14 | $138.64K 10-Q · filed 2024-11-14 | $138.64M 10-Q · filed 2023-12-11 | -$127.37M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$38.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $183.52K 10-Q · filed 2024-08-14 | -$127.33M derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $222.40K 10-Q · filed 2024-05-15 | -$127.29M derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$127.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $102.06K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $127.61M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |